|
|
||||||||
From the University "Campus Bio-Medico" (Drs. Afeltra and Vadacca), Rome, Italy; Departments of Clinical Medicine (Drs. Garzia, Mitterhofer, Galluzzo, Del Porto, Laganà, Ferri, and Amoroso) and Neurological Sciences (Drs. Finamore, Pascucci, Gasparini, and Francia), University "La Sapienza," Rome, Italy; and Department of Clinical Medicine, Immunology, and Infectious Diseases (Dr. Caccavo), University of Bari, Italy.
Address correspondence and reprint requests to Prof. A. Afeltra, University "Campus Bio-Medico," Via E. Longoni 83, 00155 Rome, Italy; e-mail: a.afeltra{at}unicampus.it
The authors assessed the prevalence of neuropsychiatric manifestations occurring in patients with systemic lupus erythematosus (NPSLE), according to the American College of Rheumatology standardized definitions for NPSLE, and evaluated the relationship between NPSLE and antiphospholipid antibodies. Sixty-one consecutive SLE patients were studied. Neuropsychiatric manifestations consistent with the diagnosis of NPSLE occurred in 44 (72%). Patients with NPSLE showed significantly higher levels of anticardiolipin antibodies.
This article has been cited by other articles:
![]() |
S Appenzeller, F Cendes, and L. Costallat Cerebellar ataxia in systemic lupus erythematosus Lupus, December 1, 2008; 17(12): 1122 - 1126. [Abstract] [PDF] |
||||
![]() |
J. M. Pego-Reigosa and D. A. Isenberg Psychosis due to systemic lupus erythematosus: characteristics and long-term outcome of this rare manifestation of the disease Rheumatology, October 1, 2008; 47(10): 1498 - 1502. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. G. Joseph, G. A. Lammie, and N. J. Scolding CNS lupus: A study of 41 patients Neurology, August 14, 2007; 69(7): 644 - 654. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A Mikdashi Proposed response criteria for neurocognitive impairment in systemic lupus erythematosus clinical trials Lupus, June 1, 2007; 16(6): 418 - 425. [Abstract] [PDF] |
||||
![]() |
T. Parikh, K. Shifteh, M.L. Lipton, J.A. Bello, and A.L. Brook Deep Brain Reversible Encephalopathy: Association with Secondary Antiphospholipid Antibody Syndrome AJNR Am. J. Neuroradiol., January 1, 2007; 28(1): 76 - 78. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-H. J. Cha, K. Furie, J. Kay, R. P. Walensky, M. E. Mullins, and E. T. Hedley-Whyte Case 39-2006 -- A 24-Year-Old Woman with Systemic Lupus Erythematosus, Seizures, and Right Arm Weakness N. Engl. J. Med., December 21, 2006; 355(25): 2678 - 2689. [Full Text] [PDF] |
||||
![]() |
R Cimaz, P L Meroni, and Y Shoenfeld Epilepsy as part of systemic lupus erythematosus and systemic antiphospholipid syndrome (Hughes syndrome) Lupus, April 1, 2006; 15(4): 191 - 197. [Abstract] [PDF] |
||||
![]() |
F-G Lehnhardt, C Scheid, U Holtik, L Burghaus, M Neveling, P Impekoven, A Ruger, M Hallek, A H Jacobs, and A Rubbert Autologous blood stem cell transplantation in refractory systemic lupus erythematodes with recurrent longitudinal myelitis and cerebral infarction Lupus, April 1, 2006; 15(4): 240 - 243. [Abstract] [PDF] |
||||
![]() |
L. Statkute, A. Traynor, Y. Oyama, K. Yaung, L. Verda, N. Krosnjar, and R. K. Burt Antiphospholipid syndrome in patients with systemic lupus erythematosus treated by autologous hematopoietic stem cell transplantation Blood, October 15, 2005; 106(8): 2700 - 2709. [Abstract] [Full Text] [PDF] |
||||
![]() |
M H Houman, M Smiti-Khanfir, I B. Ghorbell, and M Miled Systemic lupus erythematosus in Tunisia: demographic and clinical analysis of 100 patients Lupus, March 1, 2004; 13(3): 204 - 211. [Abstract] [PDF] |
||||
![]() |
O Nived, G Sturfelt, M H Liang, and P De Pablo The ACR nomenclature for CNS lupus revisited Lupus, December 1, 2003; 12(12): 872 - 876. [Abstract] [PDF] |
||||
![]() |
R. L. Brey and M. A. Petri Neuropsychiatric systemic lupus erythematosus: Miles to go before we sleep Neurology, July 8, 2003; 61(1): 9 - 10. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |